Alpha-1 antitrypsin deficiency caused by a novel mutation (p.Leu263Pro): Pi*ZQ0gaia - Q0gaia allele

Revista Portuguesa de Pneumologia (English Edition)

Volumn 21, Issue 6, 2015, Pages 341-343

  Oliveira, M J ^a   Seixas, S ^b,c   Ladeira, I ^a   Monteiro, R ^a   Shiang, T ^a   Guimaraes M ^a   Lima, R ^a  

^a CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Alpha 1 antitrypsin deficiency; COPD; Null allele

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMINOPHYLLINE; BUDESONIDE; CARBON MONOXIDE; FORMOTEROL; TIOTROPIUM BROMIDE;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTERIAL GAS; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; GENE MUTATION; HUMAN; HYPOXEMIA; IMMUNOELECTROPHORESIS; LUNG AUSCULTATION; LUNG EMPHYSEMA; MALE; POLYMERASE CHAIN REACTION; PROTEIN ELECTROPHORESIS; PROTEIN STRUCTURE;

EID: 85009265631     PISSN: None     EISSN: 21735115     Source Type: Journal    
DOI: 10.1016/j.rppnen.2015.07.002     Document Type: Article

References (13)

1. Costa CA, Santos C. Alpha-1 antitrypsin deficiency. The experience of Pulido Valente Hospital with augmentation therapy. RevPort Pneumol. 2009;15(3):473-82.
2. de Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med. 2014;276(4):311-35.
3. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818-900.
4. Stoller JK, Aboussouan LS. A review of a1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246-59.
5. de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency. Chest. 2002;122:1818-29.
6. Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, et al. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update. Arch Bronconeumol. 2015;51:185-92.
7. Bárbara C, Rodrigues F, Dias H, Cardoso J, Almeida J, Matos MJ, et al. Prevalência da doença pulmonar obstrutiva crónica emLisboa, Portugal: estudo Burden of Obstructive Lung Disease. Rev Port Pneumol. 2013;19:96-105.
8. Rodrigues LV, Costa F, Marques P, Mendonça C, Rocha J, Seixas S. Severe α-1 antitrypsin deficiency caused by Q0(Ourém) allele:clinical features, haplotype characterization and history. ClinGenet. 2012;81:462-9.
9. Rieger S, Riemer H, Mannhalter C. Multiplex PCR assay for the detection of genetic variants of alpha1-antitrypsin. Clin Chem.1999;45:688-90.
10. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr ProtocHum Genet. 2013. Chapter 7:Unit7.20.
11. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoSONE. 2012;7(10):e46688.
12. Schwarz JM, Cooper DN, Schuelke M, Seelow D. Mutation-Taster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361-2.
13. Stein PE, Carrell RW. What do dysfunctional serpins tell usabout molecular mobility and disease? Nat Struct Biol. 1995;2:96-113.